Professional Documents
Culture Documents
Art PINHO Transmissible Venereal Tumor Treated With Autohemotherapy 2013
Art PINHO Transmissible Venereal Tumor Treated With Autohemotherapy 2013
Karina Oliveira Drumond1, Ana Maria Quessada1, Silvana Maria Medeiros de Sousa Silva1,
Francisco Assis Lima Costa1, Lucilene dos Santos Silva1,
Flaviane Alves de Pinho2 & Rallyson Ramon Fernando Barbosa Lopes3
ABSTRACT
Background: Transmissible venereal tumor (TVT) is a neoplasm of round cells, that affects exclusively the canine specie.
The etiology of the tumor is unknown, but the hystiocitic hipothesis is the more accepted. It is transmitted principally by
the venereal form, but the inplant of cells can cause the disease. The clinic signs of the neoplasia are typical and include
tumoral friable mass (in shape of cauliflower), that bleed easily. The most common localization is external genitalia, but the
tumor can appears in skin surface and other organs. TVT grows rapidly (progressive phase) after transplantation, followed
by a static phase (without cell proliferation) and then may regress spontaneously (stage of regression). The regression of
the neoplasia is associated with increased infiltration of T lymphocytes and macrophages in the tumor and characterized
by increased apoptosis of tumor cells and fibrosis. The diagnosis of TVT is usually done by the physical aspect of the
tumor, and confirmed by cytology or histopathology. TVT can be prevented by castration of the animals. The treatment of
TVT is usually performed with vincristine, which has side effects, requires care in its application, and has a relatively high
cost. Thus, new therapeutic low-cost alternatives are suggested, as is the case of autohemotherapy. The autohemotherapy
technique consists of administration of autologous whole blood intramuscularly. In veterinary practice has been used suc-
cessfully to treat bovine papillomatosis and other diseases. Probably the mechanism of action of autohemotherapy is to
enhance organic immunity. This report aimed to evaluate the behavior of the transmissible venereal tumor in six dogs with
naturally transplanted tumor after treatment with autohemotherapy.
Materials, Methods & Results: Six adult bitches were clinically examined and all presented transmissible venereal tumor
located in external genitalia, adquired by natural transmission. Cytological examination confirmed the diagnosis of TVT.
The bitches were kept in kennels by one week before treatment, and it was not observed natural regression of tumor mass.
After this time the animals were submitted to treatment with autohemotherapy, which consisted of application of autologous
whole blood in the gluteal muscles, at dose of 10 mL. The applications were made weekly for seven weeks. All tumors were
measured before and after autohemotherapy and, also weekly during the treatment. All tumors were friable and bleeding
easily, multilobulated, nodulares, cauliflower-like shape, pale-pink to pale red, with surface smooth or irregular. In some
animals there were signs of secondary infection. In general, the measurement of tumor ranged from 3.0 cm to 7.1 cm be-
fore of autohemotherapy. After treatment it was observed, macroscopically, a decrease of the tumoral mass in three dogs.
Discussion: It was established as criterion for stopping treatment the time of seven weeks. Possibly if the treatment had
been extended the regression could have been completed. Probably autohemotherapy increased immunity and, consequently,
contributed to increase the body’s resistance against TVT, producing regression of tumoral mass. Therefore, the autohe-
motherapy led to macroscopic partial regression of the tumor in 50% of animals subjected to this treatment, stimulating
further research in this area.
1
K.O. Drumond, A.M. Quessada, S.M.M.S. Silva, et al. 2013. Transmissible Venereal Tumor Treated with Autohemotherapy.
Acta Scientiae Veterinariae. 41: 1107.
2
K.O. Drumond, A.M. Quessada, S.M.M.S. Silva, et al. 2013. Transmissible Venereal Tumor Treated with Autohemotherapy.
Acta Scientiae Veterinariae. 41: 1107.
Figure 1. A)- Mongrel bitch with transmissible venereal tumor in vulva before treat-
ment with autohemotherapy (AHT). B)- Same bitch of the Figure 1 A, five weeks after
treatment with AHT.
Figure 2. A)- Mongrel bitch with transmissible venereal tumor in vulva before treat-
ment with autohemotherapy (AHT). B)- Same bitch of the Figure 2 A, six weeks after
treatment with AHT.
Figure 3. A)- Mongrel bitch with transmissible venereal tumor in vulva before treat-
ment with autohemotherapy (AHT). B)- Same bitch of the Figure 3 A, six weeks after
treatment with AHT.
dog with TVT [6], and has been used to treat other Ethical approval. This research was approved by the Ethics
neoplasias in animals [13,16]. Committee on Animal Experimentation of the Federal Univer-
sity of Piaui, Teresina, Piaui, Brazil.
It was suggested that autohemotherapy led to
macroscopic partial regression of the mass tumoral Declaration of interest. The authors report no conflicts of
in 50% of animals subjected to this treatment, which interest. The authors alone are responsible for the content and
writing of the paper.
stimulates the further development of research in this
area. The autohemotherapy causes no side effects.
3
K.O. Drumond, A.M. Quessada, S.M.M.S. Silva, et al. 2013. Transmissible Venereal Tumor Treated with Autohemotherapy.
Acta Scientiae Veterinariae. 41: 1107.
REFERENCES
1 Andrade S.F., Oliveira C.M.N.L., Cotta-Luizari F., Haddad R.R., Barbour L.F., Sanches J.C. & Mendonça M.F.
1999. Normas de segurança para o uso de vincristina no tratamento de tumor venéreo transmissível canino. Clínica
Veterinária. 4(18): 32-33.
2 Andrade S.F., Sanches O.C., Gervazoni E.R., Lapa F.A.S. & Kaneko V.M. 2009. Comparação entre dois protocolos
de tratamento do tumor venéreo transmissível em cães. Clínica Veterinária. 82(14): 56-62.
3 Drumond K.O., Quessada A.M., Silva S.M.M.S., Costa F.A.L., Silva L.S., Gonçalves L.M.F. & Lopes R.R.F.B. 2008.
Regressão espontânea de tumor venéreo transmissível canino. Relato de caso. PUBVET. 2(38): 367.
4 Gonzalez C.M., Griffey S.M., Naydan D.K., Flores E., Cepeda R., Cattaneo G. & Madewell B.R. 2000. Canine
transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and
during regression after chemotherapy. Journal of Comparative Pathology. 122(4): 241-248.
5 Johnson C.A. 1994. Infecções genitais e tumor venéreo transmissível. In: Nelson R. & Couto C. (Eds). Fundamentos
de medicina interna de pequenos animais. Rio de Janeiro: Guanabara Koogan, pp.522-525.
6 Lefebvre G.N.F., Bonamin L.V. & Oliveira C.M. 2007. Tratamento de tumor venéreo transmissível (TVT) canino
utilizando Viscum album em associação à autohemoterapia. Clínica Veterinária. 12(70): 78-86.
7 Magalhães A.M., Ramadinha R.R., Barros C.S.L. & Peixoto P.V. 2001. Estudo comparativo entre citopatologia e
histopatologia no diagnóstico de neoplasias caninas. Pesquisa Veterinária Brasileira. 21(1): 23-32.
8 Martínez M.M., Ballut J.C. & Cardona J.A. 2002. Tumor venéreo transmisible (TVT) de localización extragenital.
MVZ Córdoba. 7(1): 168-170.
9 O’keefe D.A. 1997. Tumores do sistema genital e das glândulas mamárias. In: Ettinger S. & Feldman E. (Eds). Tratado
de medicina interna veterinária. 4.ed. São Paulo: Manole, pp.2344-2351.
10 Paradysz A., Fryczkowski M., Krauze-Balwińska Z. & Gajewski D. 1998. Studies on the behavior of some immu-
nologic parameters after local, endoscopic autohemotherapy in children treated for vesicoureteral reflux. Wiadomości
lekarskie. 51(suppl. 3): 114-119.
11 Pérez J., Day M.J.J. & Mozos E. 1998. Immunohistochemical study of the local inflammatory infiltrate in spontaneous
canine transmissible venereal tumour at different stages of growth. Veterinary Immunology Immunopathology. 64(2):
133-147.
12 Ramos J.K.M., Carvalho C.M.E. & Babo-Terra V.J. 2006. Tumor venéreo transmissível canino extragenital tratado
com ciclofosfamida. Nosso Clínico. 9(52): 38-42.
13 Santin A.P.I. & Brito L.A.B. 2004. Estudo da papilomatose cutânea em bovinos leiteiros: comparação de diferentes
tratamentos. Ciência Animal Brasileira. 5(1): 39-45.
14 Santos F.G.A., Vasconcelos A.C., Nunes J.E.S., Cassali G.D., Paixão T. A. & Moro L. 2005. O tumor venéreo trans-
missível canino - aspectos gerais e abordagens moleculares (revisão de literatura). Bioscience Journal. 21(3): 41-53.
15 Schürer-Waldheim F. 1933. Über die Wirkungsweise der Eigenblutbehandlung. Langenbeck’s Archives of Surgery.
239(11/12): 352-362.
16 Silva L.A.F., Veríssimo A.C.C., Viana Filho P.R.L., Fioravanti M.C.S., Linhares D., Fontgalland G.C., Romani
A.F. & Trindade B.R. 2004. Eficiência da repetição de diferentes protocolos de tratamentos para papilomatose bovina.
Revista da Faculdade de Zootecnia, Veterinária e Agronomia. 11(1): 153-165.
17 Sousa J., Saito V., Nardi A.B., Rodaski S., Guérios S.D. & Bacila M. 2000. Características e incidência do tumor
venéreo transmissível (TVT) em cães e eficiência da quimioterapia e outros tratamentos. Archives of Veterinary
Science. (5): 41-48.
1107
www.ufrgs.br/actavet